Consequently, the current study aims to virtually identify potential phytoconstituents as AChE inhibitors from T. ammi secondary metabolites, which may modulate cognitive and memory function in AD patients by influencing cholinergic and glutamatergic systems, thereby halting the progression of cognitive impairment. Here, ACHE is linked to Alzheimer disease.